Lastimado, Generose M.

HRN: 11-89-97  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/30/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/30/2022
12/06/2022
PO
500 Mg
OD
Cap Mr
Waiting Final Action 
11/30/2022
CEFTRIAXONE 1G (VIAL)
11/30/2022
12/06/2022
IV
2 Grams
OD
Cap Mr
Waiting Final Action 
12/02/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/03/2022
12/09/2022
IV INFUSION
1.5gms
Q6
Bronchiectasis , Intercurrent Pneumonia
Waiting Final Action 
12/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/06/2022
12/12/2022
IVT
4.5g IVT Now ANST Then 2.25g IVT Q8
4.5g IVT Now ANST Then 2.25g IVT Q8
Cystic Fibrosis; CAP MR
Waiting Final Action 
12/06/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
12/06/2022
12/12/2022
IVT
200mg
OD
Cystic Fibrosis; CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: